发明名称 Carbonsäureamidderivate
摘要 The invention relates to compounds of formula (I), wherein the variables have the following meanings: D means a phenyl or a pyridyl which is unsubstituted or is mono- or polysubstituted by Hal, A, OR<2>, N(R<2>)2, NO2, CN, COOR2 or CON(R<2>)2; R<1> means H, Ar, Het, cycloalkyl or A, which can be substituted by OR<2>, SR<2>, N(R<2>)2, Ar, Het, cycloalkyl, CN, COOR<2> or CON(R<2>)2; R<2> means H or A, E means phenylene which can be mono- or polysubstituted by Hal, A, OR<2>, N(R<2>)2, NO2, CN, COOR<2> or CON(R<2>)2 or piperidin-1,4-diyl, W means AR, Het or N(R<2>)2 and if E=piperidin-1,4-diyl, also R2 or cycloalkyl; and X means NH or O. These compounds are inhibitors of the coagulation factor Xa and can be used for the prevention and/or therapy of thromboembolic diseases and for treating tumours.
申请公布号 DE10063008(A1) 申请公布日期 2002.06.20
申请号 DE20001063008 申请日期 2000.12.16
申请人 MERCK PATENT GMBH 发明人 DORSCH, DIETER;MEDERSKI, WERNER;TSAKLAKIDIS, CHRISTOS;CEZANNE, BERTRAM;GLEITZ, JOHANNES;BARNES, CHRISTOPHER
分类号 C07D295/12;A61K31/17;A61K31/27;A61K31/381;A61K31/402;A61K31/405;A61K31/4172;A61K31/4402;A61K31/4406;A61K31/4409;A61K31/4412;A61K31/445;A61K31/4453;A61K31/4468;A61K31/45;A61K31/453;A61K31/4535;A61K31/4545;A61K31/495;A61K31/497;A61K31/5375;A61K31/55;A61P7/02;A61P9/00;A61P9/08;A61P9/10;A61P29/00;A61P35/00;A61P35/04;C07C271/28;C07C273/18;C07C275/28;C07C275/30;C07C303/40;C07C311/39;C07C311/46;C07C315/04;C07C317/32;C07C323/60;C07D207/26;C07D207/27;C07D209/18;C07D209/20;C07D211/20;C07D211/26;C07D211/58;C07D211/76;C07D213/56;C07D213/64;C07D213/74;C07D213/75;C07D223/10;C07D233/54;C07D233/64;C07D241/08;C07D265/32;C07D295/135;C07D295/20;C07D295/205;C07D333/24;C07D401/04;C07D401/14;C07D405/04;C07D409/12;C07D409/14;C07D417/14;(IPC1-7):C07C317/32;C07C269/02;C07C269/06;C07D213/24;C07D247/00 主分类号 C07D295/12
代理机构 代理人
主权项
地址